Literature DB >> 22534879

Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study.

Sinéad M Langan1, Richard W Groves, Tim R Card, Martin C Gulliford.   

Abstract

Pyoderma gangrenosum (PG) is an important disease with significant complications. The objectives of this study were to determine incidence and mortality of PG and strength of reported associations. A retrospective cohort study was completed using computerized medical records from the General Practice Research Database, a large representative UK database. Patients with PG and three groups of age-, sex-, and practice-matched controls--general population, rheumatoid arthritis (RA), and inflammatory bowel disease (IBD) controls--were included in the study. Incidence and mortality were determined and validation undertaken to inform diagnostic accuracy. In all there were 313 people with the median age of 59 (interquartile range 41-72) years, and of them 185 (59%) were female. The adjusted incidence rate standardized to European standard population was 0.63 (95% confidence interval (CI) 0.57-0.71) per 100,000 person-years. The risk of death was three times higher than that for general controls (adjusted hazard ratio=3.03, 95% CI 1.84-4.73, P<0.001), 72% higher than that for IBD controls (adjusted hazard ratio=1.72, 95% CI 1.17-2.59, P=0.013), with a borderline increase compared with RA controls (adjusted hazard ratio=1.55, 95% CI 1.01-2.37, P=0.045). Disease associations were present in 110 (33%) participants: IBD, n=67 (20.2%); RA, n=39 (11.8%); and hematological disorders, n=13 (3.9%). To our knowledge, there are no previous population-based studies of the epidemiology of PG, an important disease with significantly increased mortality.

Entities:  

Mesh:

Year:  2012        PMID: 22534879     DOI: 10.1038/jid.2012.130

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  47 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

2.  Databases for Clinical Research.

Authors:  Katrina Abuabara; David J Margolis
Journal:  J Invest Dermatol       Date:  2015-08       Impact factor: 8.551

Review 3.  Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review.

Authors:  Massimo Cugno; Roberta Gualtierotti; Pier Luigi Meroni; Angelo Valerio Marzano
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

4.  Pyoderma gangrenosum and inflammatory bowel disease: A cross-sectional inpatient socioeconomic study.

Authors:  David W Brodell; John C Elfar; Mary Gail Mercurio
Journal:  J Am Acad Dermatol       Date:  2015-11       Impact factor: 11.527

Review 5.  A novel topical therapy for resistant and early peristomal pyoderma gangrenosum.

Authors:  Wendy A Pearson; David A Prentice; Deborah L Sinclair; Lee Y Lim; Keryln J Carville
Journal:  Int Wound J       Date:  2019-07-12       Impact factor: 3.315

Review 6.  [Pyoderma gangrenosum].

Authors:  K Herberger
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

7.  Pyoderma gangrenosum with spleen involvement. Review of the literature and case report.

Authors:  Rodica Cosgarea; Simona Corina Senilă; Radu Badea; Loredana Ungureanu
Journal:  J Dermatol Case Rep       Date:  2016-11-13

8.  Epidemiology of pyoderma gangrenosum: Results from an Italian prospective multicentre study.

Authors:  Paola Monari; Ruggero Moro; Alberico Motolese; Cosimo Misciali; Carlotta Baraldi; Pier Alessandro Fanti; Stefano Caccavale; Mario Puviani; Daniela Olezzi; Pierfrancesco Zampieri; Giusto Trevisan; Katiuscia Nan; Chiara Fiorentini; Giovanni Pellacani; Giulio Gualdi
Journal:  Int Wound J       Date:  2018-06-06       Impact factor: 3.315

9.  Patients with pyoderma gangrenosum - analyses of the German DRG data from 2012.

Authors:  Finja Jockenhöfer; Joachim Klode; Knut Kröger; Alexander Roesch; Philipp Al Ghazal; Joachim Dissemond
Journal:  Int Wound J       Date:  2015-08-06       Impact factor: 3.315

Review 10.  Pyoderma gangrenosum: pathogenetic oriented treatment approaches.

Authors:  Uwe Wollina; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2014-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.